Flemming Ørnskov steps down as CEO in Shire - the future is uncertain
CEO in Shire, Flemming Ørnskov, steps down after Takeda completed its acquisition of the company. He will continue as advisor for Takeda for three months, but what comes next is unknown.
After six years as head of Irish drug group Shire, Danish Flemming Ørnskov has handed in his resignation.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
